Developing a novel therapy for Alzheimer's disease using a microbe inhibitor.
Industry: Health Care
First Day Return: +93.5%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 04/12/2019 |
Offer Price | $17.00 |
Price Range $16.00 - $18.00 | |
Offer Shares (mm) | 4.4 |
Deal Size ($mm) | $75 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 05/08/2019 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $75 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | South San Francisco, CA, United States |
Founded | 2012 |
Employees at IPO | 19 |
Website www.cortexyme.com |